HRT and cardiovascular events

The age hypothesis does not stand up to scrutiny

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8149 (Published 3 December 2012)
Cite this as: BMJ 2012;345:e8149

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Klim McPherson, visiting professor of public health epidemiology1
  1. 1New College, Oxford OX1 3BN, UK
  1. klim.mcpherson{at}new.ox.ac.uk

Schierbeck and colleagues suggested that “initiation of hormone replacement therapy in women early after menopause significantly reduces the risk of the combined endpoint of mortality, myocardial infarction, or heart failure.”1 They invoke …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL